Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines
Top Cited Papers
Open Access
- 7 May 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (5), e33788
- https://doi.org/10.1371/journal.pone.0033788
Abstract
To improve cancer therapy, it is critical to target metastasizing cells. Circulating tumor cells (CTCs) are rare cells found in the blood of patients with solid tumors and may play a key role in cancer dissemination. Uncovering CTC phenotypes offers a potential avenue to inform treatment. However, CTC transcriptional profiling is limited by leukocyte contamination; an approach to surmount this problem is single cell analysis. Here we demonstrate feasibility of performing high dimensional single CTC profiling, providing early insight into CTC heterogeneity and allowing comparisons to breast cancer cell lines widely used for drug discovery. We purified CTCs using the MagSweeper, an immunomagnetic enrichment device that isolates live tumor cells from unfractionated blood. CTCs that met stringent criteria for further analysis were obtained from 70% (14/20) of primary and 70% (21/30) of metastatic breast cancer patients; none were captured from patients with non-epithelial cancer (n = 20) or healthy subjects (n = 25). Microfluidic-based single cell transcriptional profiling of 87 cancer-associated and reference genes showed heterogeneity among individual CTCs, separating them into two major subgroups, based on 31 highly expressed genes. In contrast, single cells from seven breast cancer cell lines were tightly clustered together by sample ID and ER status. CTC profiles were distinct from those of cancer cell lines, questioning the suitability of such lines for drug discovery efforts for late stage cancer therapy. For the first time, we directly measured high dimensional gene expression in individual CTCs without the common practice of pooling such cells. Elevated transcript levels of genes associated with metastasis NPTN, S100A4, S100A9, and with epithelial mesenchymal transition: VIM, TGFß1, ZEB2, FOXC1, CXCR4, were striking compared to cell lines. Our findings demonstrate that profiling CTCs on a cell-by-cell basis is possible and may facilitate the application of ‘liquid biopsies’ to better model drug discovery.Keywords
This publication has 62 references indexed in Scilit:
- Triple-negative breast cancer: Molecular features, pathogenesis, treatment and current lines of researchCancer Treatment Reviews, 2010
- S100A4 and Metastasis: A Small Actor Playing Many RolesThe American Journal of Pathology, 2010
- Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotypeBritish Journal of Cancer, 2010
- Roles of TGFβ in metastasisCell Research, 2008
- TGF-β mediatesPTENsuppression and cell motility through calcium-dependent PKC-α activation in pancreatic cancer cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- High Throughput Gene Expression Measurement with Real Time PCR in a Microfluidic Dynamic ArrayPLOS ONE, 2008
- Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 statusBreast Cancer Research, 2007
- Oxidative stress pathways highlighted in tumor cell immortalization: association with breast cancer outcomeOncogene, 2007
- HER2-Positive Circulating Tumor Cells Indicate Poor Clinical Outcome in Stage I to III Breast Cancer PatientsClinical Cancer Research, 2006
- Solving the “World-to-Chip” Interface Problem with a Microfluidic MatrixAnalytical Chemistry, 2003